{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:52:23Z","timestamp":1778795543781,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100388"],"award-info":[{"award-number":["81100388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470344"],"award-info":[{"award-number":["81470344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00277-018-3585-1","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T20:25:09Z","timestamp":1552681509000},"page":"1009-1020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies"],"prefix":"10.1007","volume":"98","author":[{"given":"Yu-Lin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,21]]},"reference":[{"key":"3585_CR1","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD (2017) Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis 64(1):87\u201391"},{"key":"3585_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.beha.2006.09.003","volume":"20","author":"P Ljungman","year":"2007","unstructured":"Ljungman P (2007) Risk assessment in haematopoietic stem cell transplantation: viral status. Best Pract Res Clin Haematol 20:209\u2013217","journal-title":"Best Pract Res Clin Haematol"},{"key":"3585_CR3","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbmt.2010.03.020","volume":"16","author":"N Cantoni","year":"2010","unstructured":"Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, Halter J, Heim D, Tichelli A, Gratwohl A (2010) Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant 16:1309\u20131314","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/infdis\/153.3.478","volume":"153","author":"JD Meyers","year":"1986","unstructured":"Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153:478\u2013488","journal-title":"J Infect Dis"},{"key":"3585_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/00007890-200209150-00023","volume":"74","author":"SF Lacey","year":"2002","unstructured":"Lacey SF, Gallez-Hawkins G, Crooks M, Martinez J, Senitzer D, Forman SJ, Spielberger R, Zaia JA, Diamond DJ (2002) Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants. Transplantation 74:722\u2013732","journal-title":"Transplantation"},{"key":"3585_CR6","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.bbmt.2010.02.007","volume":"16","author":"X-H Luo","year":"2010","unstructured":"Luo X-H, Huang X-J, Liu K-Y, Xu L-P, Liu D-H (2010) Protective immunity transferred by infusion of cytomegalovirus-specific CD8+ T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 16:994\u20131004","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1399-3062.2012.00722.x","volume":"15","author":"XH Luo","year":"2013","unstructured":"Luo XH, Huang XJ, Li D, Liu KY, Xu LP, Liu DH (2013) Immune reconstitution to cytomegalovirus following partially matched-related donor transplantation: impact of in vivo T-cell depletion and granulocyte colony-stimulating factor-primed peripheral blood\/bone marrow mixed grafts. Transpl Infect Dis 15:22\u201333","journal-title":"Transpl Infect Dis"},{"key":"3585_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/631951","volume":"2014","author":"X-H Luo","year":"2014","unstructured":"Luo X-H, Chang Y-J, Huang X-J (2014) Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation. J Immunol Res 2014:1\u201312","journal-title":"J Immunol Res"},{"key":"3585_CR9","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","volume":"118","author":"AH Elmaagacli","year":"2011","unstructured":"Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M, Christoph S, Gromke T, Kordelas L, Ottinger HD (2011) Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 118:1402\u20131412","journal-title":"Blood"},{"key":"3585_CR10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","volume":"122","author":"ML Green","year":"2013","unstructured":"Green ML, Leisenring WM, Xie H, Walter RB, Mielcarek M, Sandmaier BM, Riddell SR, Boeckh M (2013) CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 122:1316\u20131324","journal-title":"Blood"},{"key":"3585_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbmt.2008.10.023","volume":"15","author":"CE Behrendt","year":"2009","unstructured":"Behrendt CE, Rosenthal J, Bolotin E, Nakamura R, Zaia J, Forman SJ (2009) Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy. Biol Blood Marrow Transplant 15:54\u201360","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbmt.2013.10.003","volume":"20","author":"S Manjappa","year":"2014","unstructured":"Manjappa S, Bhamidipati PK, Stokerl-Goldstein KE, DiPersio JF, Uy GL, Westervelt P, Liu J, Schroeder MA, Vij R, Abboud CN (2014) Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen. Biol Blood Marrow Transplant 20:46\u201352","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbmt.2003.08.011","volume":"10","author":"R Nakamura","year":"2004","unstructured":"Nakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K, Hensel N, Childs R, Barrett AJ (2004) Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant 10:49\u201357","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR14","first-page":"46","volume":"58","author":"A V\u00edtek","year":"2012","unstructured":"V\u00edtek A, Luk\u00e1\u0161ov\u00e1 M, Chudomel V, M\u00e1jsk\u00fd A, Sou\u010dek J, Kobylka P, Ko\u0159\u00ednkov\u00e1 P, Loudov\u00e1 M, Dobrovoln\u00e1 M, Mat\u011bjkov\u00e1 E (2012) Transplantation of haematopoietic cells and its role in the treatment of haematopoiesis during the last 25 years. Vnitrni Lekarstvi 58:46\u201355","journal-title":"Vnitrni Lekarstvi"},{"key":"3585_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16","journal-title":"Trials"},{"key":"3585_CR16","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008\u20132012","journal-title":"JAMA"},{"key":"3585_CR17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"3585_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"3585_CR19","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","volume":"48","author":"SL Spruance","year":"2004","unstructured":"Spruance SL, Reid JE, Grace M, Samore M (2004) Hazard ratio in clinical trials. Antimicrob Agents Chemother 48:2787\u20132792","journal-title":"Antimicrob Agents Chemother"},{"key":"3585_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455\u2013463","journal-title":"Biometrics"},{"key":"3585_CR21","unstructured":"Wells G, Shea B, O\u2019connell D, Peterson J, Welch V, Losos M, Tugwell P. 2011. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In Ottawa, Ontario, Canada: Ottawa Hospital Research Institute. Accessed at www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm . Accessed 30 Sept 2018"},{"key":"3585_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbmt.2009.09.019","volume":"16","author":"JC Beck","year":"2010","unstructured":"Beck JC, Wagner JE, DeFor TE, Brunstein CG, Schleiss MR, Young J-A, Weisdorf DH, Cooley S, Miller JS, Verneris MR (2010) Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. Biol Blood Marrow Transplant 16:215\u2013222","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR23","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","volume":"95","author":"AE Broers","year":"2000","unstructured":"Broers AE, van der Holt R, van Esser JW, Gratama J-W, Henzen-Logmans S, Kuenen-Boumeester V, L\u00f6wenberg B, Cornelissen JJ (2000) Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell\u2013depleted stem cell transplantation. Blood 95:2240\u20132245","journal-title":"Blood"},{"key":"3585_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcv.2015.12.003","volume":"75","author":"Y Chen","year":"2016","unstructured":"Chen Y, Xu L-P, Liu K-Y, Chen H, Chen Y-H, Zhang X-H, Wang Y, Wang F-R, Han W, Wang J-Z (2016) Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus. J Clin Virol 75:10\u201315","journal-title":"J Clin Virol"},{"key":"3585_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bbmt.2015.09.006","volume":"22","author":"J Inagaki","year":"2016","unstructured":"Inagaki J, Noguchi M, Kurauchi K, Tanioka S, Fukano R, Okamura J (2016) Effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia. Biol Blood Marrow Transplant 22:300\u2013306","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR26","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/bmt.2013.49","volume":"48","author":"S Ito","year":"2013","unstructured":"Ito S, Pophali P, Wu C, Koklanaris EK, Superata J, Fahle GA, Childs R, Battiwalla M, Barrett AJ (2013) CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML. Bone Marrow Transplant 48:1313\u20131316","journal-title":"Bone Marrow Transplant"},{"key":"3585_CR27","first-page":"413","volume":"5","author":"N Jacobsen","year":"1990","unstructured":"Jacobsen N, Badsberg JH, L\u00f6nnqvist B, Ringden O, Volin L, Rajantie J, Nikoskelainen J, Keiding N (1990) Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. Bone Marrow Transplant 5:413\u2013418","journal-title":"Bone Marrow Transplant"},{"key":"3585_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00277-014-2190-1","volume":"94","author":"JE Jang","year":"2015","unstructured":"Jang JE, Kim SJ, Cheong J-W, Hyun SY, Kim YD, Kim YR, Kim JS, Min YH (2015) Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia. Ann Hematol 94:275\u2013282","journal-title":"Ann Hematol"},{"key":"3585_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/bjh.12875","volume":"166","author":"M Jeljeli","year":"2014","unstructured":"Jeljeli M, Khourouj GE, Porcher R, Fahd M, Leveill\u00e9 S, Yakouben K, Ouach\u00e9e-Chardin M, LeGoff J, Cordeiro DJ, P\u00e9dron B (2014) Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children. Br J Haematol 166:229\u2013239","journal-title":"Br J Haematol"},{"key":"3585_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/01.tp.0000190102.15300.7d","volume":"81","author":"DH Kim","year":"2006","unstructured":"Kim DH, Won DI, Lee NY, Sohn SK, Baek JH, Kim JG, Suh JS, Lee KB (2006) Survival benefit of asymptomatic cytomegalovirus reactivation after HLA-identical allogeneic peripheral blood stem cell transplantation. Transplantation 81:101\u2013108","journal-title":"Transplantation"},{"key":"3585_CR31","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1080\/10428194.2016.1217524","volume":"58","author":"M Koldehoff","year":"2017","unstructured":"Koldehoff M, Ross SR, D\u00fchrsen U, Beelen DW, Elmaagacli AH (2017) Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphoma. Leuk Lymphoma 58:822\u2013833","journal-title":"Leuk Lymphoma"},{"key":"3585_CR32","first-page":"107","volume":"55","author":"X Lin","year":"2016","unstructured":"Lin X, Ou Y, Long H, Huang Y, Song C, Lu Z, Guo K, Wu B, Xu J (2016) Cytomegalovirus infection after haploidentical stem cell transplantation may reduce relapse risk in leukemia. Zhonghua nei ke za zhi 55:107\u2013110","journal-title":"Zhonghua nei ke za zhi"},{"key":"3585_CR33","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.bbmt.2014.02.015","volume":"20","author":"J Mariotti","year":"2014","unstructured":"Mariotti J, Maura F, Spina F, Roncari L, Dodero A, Farina L, Montefusco V, Carniti C, Sarina B, Patriarca F (2014) Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 20:885\u2013890","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR34","first-page":"123","volume":"95","author":"X Niu","year":"2015","unstructured":"Niu X, He H, Zhou R, Xu X (2015) Impact of human cytomegalovirus viremia on relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients. Zhonghua Yi Xue Za Zhi 95:123\u2013125","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"3585_CR35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/bmt.2016.89","volume":"51","author":"M Ramanathan","year":"2016","unstructured":"Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn K, Chen M, Green J, Laughlin M, Lazarus H, Marks D (2016) Impact of early CMV reactivation in cord blood stem cell recipients in the current era. Bone Marrow Transplant 51:1113\u20131120","journal-title":"Bone Marrow Transplant"},{"key":"3585_CR36","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","volume":"122","author":"M Schmidt-Hieber","year":"2013","unstructured":"Schmidt-Hieber M, Labopin M, Beelen D, Volin L, Ehninger G, Finke J, Soci\u00e9 G, Schwerdtfeger R, Kr\u00f6ger N, Ganser A (2013) CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT. Blood 122:3359\u20133364","journal-title":"Blood"},{"key":"3585_CR37","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","volume":"21","author":"K Takenaka","year":"2015","unstructured":"Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N (2015) Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: the Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Biol Blood Marrow Transplant 21:2008\u20132016","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR38","doi-asserted-by":"crossref","unstructured":"Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN (2016) Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis. Blood 127(20):2427\u20132438","DOI":"10.1182\/blood-2015-11-679639"},{"key":"3585_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1600-0609.2007.01006.x","volume":"80","author":"A Tomonari","year":"2008","unstructured":"Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kato S, Kasahara S, Iseki T, Yamaguchi T, Tojo A (2008) Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan. Eur J Haematol 80:251\u2013257","journal-title":"Eur J Haematol"},{"key":"3585_CR40","volume":"7","author":"J-H Yoon","year":"2016","unstructured":"Yoon J-H, Lee S, Kim H-J, Jeon Y-W, Lee S-E, Cho B-S, Lee D-G, Eom K-S, Kim Y-J, Min C-K (2016) Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission. Oncotarget 7:17230","journal-title":"Oncotarget"},{"key":"3585_CR41","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.bbmt.2010.08.001","volume":"16","author":"DL Porter","year":"2010","unstructured":"Porter DL, Alyea EP, Antin JH, DeLima M, Estey E, Falkenburg J, Hardy N, Kroeger N, Leis J, Levine J (2010) NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on treatment of relapse after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 16:1467\u20131503","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR42","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1200\/JCO.2005.08.136","volume":"23","author":"F Baron","year":"2005","unstructured":"Baron F, Maris MB, Sandmaier BM, Storer BE, Sorror M, Diaconescu R, Woolfrey AE, Chauncey TR, Flowers ME, Mielcarek M (2005) Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol 23:1993\u20132003","journal-title":"J Clin Oncol"},{"key":"3585_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.bmt.1705891","volume":"41","author":"M Ishaqi","year":"2008","unstructured":"Ishaqi M, Afzal S, Dupuis A, Doyle J, Gassas A (2008) Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia. Bone Marrow Transplant 41:245\u2013252","journal-title":"Bone Marrow Transplant"},{"key":"3585_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/bmt.2008.267","volume":"43","author":"X Luo","year":"2009","unstructured":"Luo X, Chang Y, Xu L, Liu D, Liu K, Huang X (2009) The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched\/haploidentical hematopoietic SCT. Bone Marrow Transplant 43:29\u201336","journal-title":"Bone Marrow Transplant"},{"key":"3585_CR45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/sj.bmt.1704689","volume":"34","author":"E Nemecek","year":"2004","unstructured":"Nemecek E, Gooley T, Woolfrey A, Carpenter P, Matthews D, Sanders J (2004) Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia. Bone Marrow Transplant 34:799\u2013806","journal-title":"Bone Marrow Transplant"},{"key":"3585_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1182\/blood-2006-10-043299","volume":"110","author":"MS Tallman","year":"2007","unstructured":"Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, P\u00e9rez WS (2007) Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood 110:409\u2013417","journal-title":"Blood"},{"key":"3585_CR47","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1182\/blood-2011-11-389809","volume":"119","author":"X-J Huang","year":"2012","unstructured":"Huang X-J, Zhu H-H, Chang Y-J, Xu L-P, Liu D-H, Zhang X-H, Jiang B, Jiang Q, Jiang H, Chen Y-H (2012) The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate-or high-risk acute myeloid leukemia in first complete remission. Blood 119:5584\u20135590","journal-title":"Blood"},{"key":"3585_CR48","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1600-6143.2012.04008.x","volume":"12","author":"NK Tchao","year":"2012","unstructured":"Tchao NK, Turka LA (2012) Lymphodepletion and homeostatic proliferation: implications for transplantation. Am J Transplant 12:1079\u20131090","journal-title":"Am J Transplant"},{"key":"3585_CR49","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.bbmt.2014.01.018","volume":"20","author":"G Lugthart","year":"2014","unstructured":"Lugthart G, van Ostaijen-Ten Dam MM, Jol-van der Zijde CM, van Holten TC, Kester MG, Heemskerk MH, Bredius RG, van Tol MJ, Lankester AC (2014) Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20:655\u2013661","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR50","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1182\/blood-2002-11-3472","volume":"102","author":"M Hakki","year":"2003","unstructured":"Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P, White K, Corey L, Boeckh M (2003) Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy and subclinical reactivation. Blood 102:3060\u20133067","journal-title":"Blood"},{"key":"3585_CR51","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood-2005-11-012864","volume":"108","author":"D Lilleri","year":"2006","unstructured":"Lilleri D, Gerna G, Fornara C, Lozza L, Maccario R, Locatelli F (2006) Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 108:1406\u20131412","journal-title":"Blood"},{"key":"3585_CR52","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1182\/blood.V97.5.1232","volume":"97","author":"K Cwynarski","year":"2001","unstructured":"Cwynarski K, Ainsworth J, Cobbold M, Wagner S, Mahendra P, Apperley J, Goldman J, Craddock C, Moss PA (2001) Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 97:1232\u20131240","journal-title":"Blood"},{"key":"3585_CR53","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1182\/blood.V98.5.1358","volume":"98","author":"JW Gratama","year":"2001","unstructured":"Gratama JW, van Esser JW, Lamers CH, Tournay C, L\u00f6wenberg B, Bolhuis RL, Cornelissen JJ (2001) Tetramer-based quantification of cytomegalovirus (CMV)\u2013specific CD8+ T lymphocytes in T-cell\u2013depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98:1358\u20131364","journal-title":"Blood"},{"key":"3585_CR54","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbmt.2006.05.008","volume":"12","author":"R Parkman","year":"2006","unstructured":"Parkman R, Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E, Kurtzberg J, Wagner JE, Kernan NA (2006) Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant 12:919\u2013927","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9288","key":"3585_CR55","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(01)06275-4","volume":"358","author":"D Nachbaur","year":"2001","unstructured":"Nachbaur D, Bonatti H, Oberaigner W, Eibl B, Kropshofer G, Gastl G, Nussbaumer W, Einsele H, Larcher C (2001) Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donors. Lancet 358(9288):1157\u20131159","journal-title":"Lancet"},{"issue":"35","key":"3585_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/CJI.0b013e31824b3b14","volume":"1997","author":"G Alatrash","year":"2012","unstructured":"Alatrash G, Ono Y, Sergeeva A, Sukhumalchandra P, Zhang M, John LSS, Yang T-H, Ruisaard K, Armistead PM, Mittendorf EA (2012) The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1. J Immunother 1997(35):309","journal-title":"J Immunother"},{"key":"3585_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/sj.leu.2402748","volume":"17","author":"S Hermouet","year":"2003","unstructured":"Hermouet S, Sutton C, Rose T, Greenblatt R, Corre I, Garand R, Neves A, Bataille R, Casey J (2003) Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma. Leukemia 17:185\u2013195","journal-title":"Leukemia"},{"key":"3585_CR58","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","volume":"119","author":"B Foley","year":"2012","unstructured":"Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, Lopez-Verg\u00e8s S, Lanier LL, Weisdorf D, Miller JS (2012) Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 119:2665\u20132674","journal-title":"Blood"},{"key":"3585_CR59","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/leu.2012.374","volume":"27","author":"W Scheper","year":"2013","unstructured":"Scheper W, van Dorp S, Kersting S, Pietersma F, Lindemans C, Hol S, Heijhuurs S, Sebestyen Z, Gr\u00fcnder C, Marcu-Malina V (2013) \u03b3\u03b4T cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia 27:1328\u20131338","journal-title":"Leukemia"},{"key":"3585_CR60","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.161.5.2365","volume":"161","author":"JM Fletcher","year":"1998","unstructured":"Fletcher JM, Prentice HG, Grundy JE (1998) Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. J Immunol 161:2365\u20132374","journal-title":"J Immunol"},{"key":"3585_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbmt.2009.06.010","volume":"16","author":"CENR Behrendt","year":"2010","unstructured":"Behrendt CENR, Zaia J (2010) Institution affects association between CMV seronegative graft and leukemic relapse after pediatric HCT. Biol Blood Marrow Transplant 16:133\u2013135","journal-title":"Biol Blood Marrow Transplant"},{"key":"3585_CR62","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","volume":"20","author":"MJ Cannon","year":"2010","unstructured":"Cannon MJ, Schmid DS, Hyde TB (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20:202\u2013213","journal-title":"Rev Med Virol"},{"key":"3585_CR63","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.4049\/jimmunol.176.4.2645","volume":"176","author":"SR Hadrup","year":"2006","unstructured":"Hadrup SR, Strindhall J, K\u00f8llgaard T, Seremet T, Johansson B, Pawelec G, thor Straten P, Wikby A (2006) Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 176:2645\u20132653","journal-title":"J Immunol"},{"key":"3585_CR64","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.exger.2007.01.005","volume":"42","author":"RP Stowe","year":"2007","unstructured":"Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R (2007) Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 42:563\u2013570","journal-title":"Exp Gerontol"},{"key":"3585_CR65","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","volume":"12","author":"B George","year":"2010","unstructured":"George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K (2010) Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis 12:322\u2013329","journal-title":"Transpl Infect Dis"},{"key":"3585_CR66","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.bmt.1703927","volume":"31","author":"S Matthes-Martin","year":"2003","unstructured":"Matthes-Martin S, Lion T, Aberle SW, Fritsch G, Lawitschka A, Bittner B, Frommlet F, Gadner H, Peters C (2003) Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality. Bone Marrow Transplant 31:803\u2013808","journal-title":"Bone Marrow Transplant"},{"key":"3585_CR67","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/0140-6736(91)90201-Y","volume":"337","author":"PJ Easterbrook","year":"1991","unstructured":"Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR (1991) Publication bias in clinical research. Lancet 337:867\u2013872","journal-title":"Lancet"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3585-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3585-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3585-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T15:17:26Z","timestamp":1694704646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3585-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,21]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["3585"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3585-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,21]]},"assertion":[{"value":"10 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the local institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}